期刊
ORGANIC LETTERS
卷 23, 期 6, 页码 2258-2262出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.orglett.1c00387
关键词
-
资金
- Pfizer Inc.
- Bristol-Myers Squibb
A concise stereocontrolled synthetic route to the C-2-symmetric azatetraquinane 1 (or its enantiomer) has been described, involving innovation in methodology for [3+2] cycloaddition and stereochemical control.
Concise stereocontrolled synthetic routes to the C-2-symmetric azatetraquinane 1 (or, also, the enantiomer) are described. The successful execution of the synthesis involved innovation in the methodology for [3+2] cycloaddition and stereochemical control.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据